Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5701717 | Journal of Thoracic Oncology | 2017 | 34 Pages |
Abstract
Molecular expression subtypes of lung AD and SCC demonstrate key and reproducible differences in immune host response. Evaluation of tumor expression subtypes as potential biomarkers for immunotherapy should be investigated.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Hawazin DrPH, Gregory M. DrPH, Jonathan S. MD, D. Neil MD, Charles M. PhD, Myla MD,